Olema Pharmaceuticals, Inc.

Nasdaq:OLMA

Pharmaceutical Preparations·SAN FRANCISCO, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/18/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/6/24	→
↓

Earnings Releases (8-K)

21 shown

Filed	Period
1/12/26	Q4 FY2026	→
11/10/25	Q4 FY2025	→
8/11/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/18/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
↓

News (8-K)

35 shown

Filed	Type	Description
1/30/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/19/25	Other	Other Events	→
11/18/25	Other	Other Events	→
10/20/25	Reg FD	Regulation FD Disclosure	→
9/2/25	Reg FD	Regulation FD Disclosure	→
6/13/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

26 shown

Filed	Form	Description
12/11/25	S-3ASR	S-3ASR	→
11/19/25	424B5	424B5	→
11/18/25	S-3MEF	S-3MEF	→
11/18/25	424B5	424B5	→
4/28/25	ARS	ARS	→
3/18/25	S-8	S-8	→
↓

Filing History(516 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Mar 6, 2026

0000315066-26-000648

—

11.3 KB

Mar 5, 2026

0001749432-26-000004

Mar 3, 2026

15.7 KB

144

Mar 4, 2026

0001959173-26-001904

—

7.7 KB

144

Mar 4, 2026

0001959173-26-001863

—

4.7 KB

144

Mar 3, 2026

0001959173-26-001810

—

4.2 KB

144

Feb 27, 2026

0001959173-26-001604

—

7.1 KB

144

Feb 24, 2026

0001959173-26-001425

—

6.5 KB

144

Feb 23, 2026

0001959173-26-001362

—

5.9 KB

144

Feb 23, 2026

0001959173-26-001333

—

5.9 KB

Feb 17, 2026

0002110895-26-000005

Feb 2, 2026

6.8 KB

Feb 17, 2026

0002110895-26-000004

Jan 30, 2026

18.1 KB

SCHEDULE 13G/A

Feb 17, 2026

0001274173-26-000089

—

11.7 KB

SCHEDULE 13G/A

Feb 17, 2026

0001193125-26-054823

—

8.7 KB

SCHEDULE 13G/A

Feb 13, 2026

0001172661-26-000718

—

11.0 KB

144

Feb 12, 2026

0001959173-26-000923

—

5.4 KB

SCHEDULE 13G

Feb 5, 2026

0000315066-26-000501

—

11.1 KB

Feb 4, 2026

0001905871-26-000002

Feb 2, 2026

13.8 KB

Feb 4, 2026

0001831216-26-000005

Feb 2, 2026

13.8 KB

Feb 4, 2026

0001749432-26-000002

Feb 2, 2026

13.8 KB

Feb 4, 2026

0001831218-26-000002

Feb 2, 2026

14.1 KB

8-K

Jan 30, 2026

0001193125-26-0317928-K

Jan 27, 2026

208.0 KB

Jan 21, 2026

0001831410-26-000004

Jan 20, 2026

5.7 KB

144

Jan 20, 2026

0001959173-26-000374

—

5.3 KB

Jan 16, 2026

0001831410-26-000002

Jan 14, 2026

5.7 KB

Jan 15, 2026

0001579397-26-000002

Jan 13, 2026

6.7 KB

25 filings shown

Filed	Form	Description
4/28/25	DEFA14A	DEFA14A	→
4/28/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/28/23	DEFA14A	DEFA14A	→
4/28/23	DEF 14A	DEF 14A	→
↓

Olema Pharmaceuticals, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(516 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/5/26	4	4	→
2/17/26	4	4	→
2/17/26	3	3	→
2/4/26	4	4	→
2/4/26	4	4	→
2/4/26	4	4	→
↓

Filed	Form	Description
3/6/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
3/4/26	144	144	→
3/4/26	144	144	→
3/3/26	144	144	→
2/27/26	144	144	→
2/24/26	144	144	→
↓